Mayne Pharma Group Ltd (MYX)

Sydney
0.380
-0.005(-1.30%)
  • Volume:
    1,051,136
  • Bid/Ask:
    0.375/0.380
  • Day's Range:
    0.370 - 0.380
Earnings results expected in 8 days

MYX Overview

Prev. Close
0.385
Day's Range
0.37-0.38
Revenue
388.82M
Open
0.38
52 wk Range
0.2-0.425
EPS
-0.05
Volume
1,051,136
Market Cap
661.13M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
4,147,991
P/E Ratio
-
Beta
1
1-Year Change
32.63%
Shares Outstanding
1,739,815,508
Next Earnings Date
25 Aug 2022
What is your sentiment on Mayne Pharma?
or
Vote to see community's results!

Mayne Pharma Group Ltd News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Mayne Pharma Group Ltd Analysis

Mayne Pharma Group Ltd Company Profile

Mayne Pharma Group Ltd Company Profile

Employees
967
Market
Australia

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing generic pharmaceuticals. The Company operates through four segments: Metrics Contract Services (MCS), International, Branded Products Division (BPD) and Portfolio Products Division (PPD). The MCS segment is engaged in providing contract pharmaceutical development, manufacturing and analytical services to third-party customers, principally in the United States. The PPD segment distributes established products (branded and generic) in the United States on a portfolio basis. The BPD segment distributes medically differentiated specialty products in United States. Its International segment manufactures and sells branded and generic pharmaceutical product globally and the provision of contract development and manufacturing services to third party customers. Its products include Doxycycline Capsules, Oxycodone IR Tablets, Erythromycin Capsules and others.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyBuyBuyNeutral
Technical IndicatorsBuyBuyBuyStrong BuyStrong Buy
SummaryStrong BuyBuyBuyStrong BuyBuy